Market Trends of Lacrimal Duct Stent Tube Industry
This section covers the major market trends shaping the Lacrimal Duct Stent Tube Market according to our research experts:
Bicanalicular Lacrimal Duct Stent Tube is Expected to Hold Significant Share in the Market During the Forecast Period
Bicanalicular lacrimal intubation is a successful treatment for children with nasolacrimal duct obstruction, and the younger the age of the children, the higher the success rate. Bicanalicular lacrimal tubes have two probes with an intervening stent. One probe is passed through the upper punctum and the other through the lower punctum. The probes are removed, and the free ends of the silicone tube are tied in the nose and sometimes secured with a suture. The longer the duration of the tube retention, the better the results, with the best results between 3 and 12 months. The increased research funding on eye disorders increases the scope and usage of the eye-related devices like bicanalicular lacrimal ducts stent tubes, which may drive the market over the forecast period.
The studies showing the reduced complications of bicanalicular stents are boosting the usage of these stents. For instance, as per the report published by the Journal of Ophthalmology in March 2021, silicone tube repositioning guiding by using a memory wire probe is an optional technique in the treatment of prolapse of silicone tubes in bicanalicular nasal iintubation.
The comparative studies of bicanalicular lacrimal intubation versus monocanalicular lacrimal intubation help reveal the advantages of bicanalicular lacrimal intubation over monocanalicular lacrimal intubation, which is expected to drive the market's growth through this segment. For instance, as per the study published by Frontiers in July 2022, endoscopic dacryocystorhinostomy with pushed bicanalicular intubation is easily manipulated and has a promising surgical outcome over pulled monocanalicular intubation. Hence, the better outcomes of bicanalicular intubation using a stent tube are expected to drive the market over the forecast period.
North America is Expected to Have Significant Growth in the Market Over the Forecast Period
North America is expected to have significant growth in the overall market throughout the forecast period. The United States holds the largest market share due to better regulations of surgical devices and growing awareness among the population to approach such procedures in case of lacrimal duct obstruction and other associated problems. The companies in the country also have well-established direct channel collaborations with hospitals and clinics.
The high burden of nasolacrimal duct obstruction and new studies using lacrimal sten tubes in the region are boosting the demand for lacrimal stents in the region, thus driving the market in the region. As per the report published by the American Academy of Ophthalmology in November 2022, congenital nasolacrimal duct obstruction occurs in approximately 5% of normal newborn infants, and the blockage occurs most commonly at the valve of Hasner at the distal end of the duct. Hence, the high burden of congenital nasolacrimal duct obstruction increases the demand for a lacrimal stent for maintenance.
The new studies on lacrimal stents reveal the comparative efficacy of products that can impact the market's growth. For instance, as per the study report published by IOVS Journal in June 2021, both the Crawford and Nunchaku style lacrimal stents showed equivalent rates of improvement in epiphora during the short- and long-term follow-up visits. Hence, the stent studies help find out the efficacy of the products in the management of lacrimal disorders, which may also drive the market over the forecast period.
